News » Money
Jul 23, 4:38 PM EDT

Delta, Apple, GlaxoSmithKline, Biogen, and Puma Biotechnology are big market movers

Business Video

Buy AP Photo Reprints
Greece's Debt Threatens to Spread
State budget
gaps map
Auto industry problems trickle down, punish Tennessee county
Women give old Derby hats a makeover in tough economy
S.C. town deals with highest unemployment in South
How mortgages were bundled and sold as securities
Tracking the $700 billion financial bailout
Tracking the year's job losses
State-by-state foreclosures since 2007
Credit crisis explained
Presidents and their economic legacies
Lexicon of the financial crisis
Americans' addiction to debt
Are Stocks Bouncing Back?

NEW YORK (AP) -- Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:


Delta Air Lines Inc., up $1.47 to $39.15

The airline's second-quarter earnings topped analysts' expectations, as passengers flew more miles at higher average fares and fuel spending declined.

GlaxoSmithKline Plc., down $3.18 to $50.04

The drug developer cut its full-year earnings forcast after reporting a decline in quarterly profit, partly on lower sales.

Puma Biotechnology Inc., up $174.40 to $223.43

The biotechnology company reported positive results from a key late-stage study of a potential breast-cancer treatment.


Apple Inc., up $2.47 to $97.19

The technology company said quarterly profit rose at its highest rate in two years as shipments of iPhones jumped 13 percent.

Xilinx Inc., down $6.89 to $41.26

The technology company reported lower-than-expected revenue and set its revenue guidance below Wall Street expectations.

Biogen Idec Inc., up $33.93 to $337.60

The biotechnology company's financial results topped expectations on multiple sclerosis drug sales and it boosted its guidance.

Intuitive Surgical Inc., up $69.47 to $461.63

The maker of surgical systems and devices reported a drop in quarterly profit, but the results topped Wall Street expectations.

© 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Learn more about our Privacy Policy and Terms of Use.